Business
Notice of Results and Investor Presentation
Notice of Results and Investor Presentation.

About this update from Ekf Diagnostics Holdings Plc
[{"type":"text","content":"\n\n \nEKF Diagnostics Holdings plc\n(\"EKF\" or the \"Company\")\n \nNotice of Interim Results and Investor Presentation\n \nEKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed global diagnostics business, will announce its interim results for the six months ended 30 June 2024 on Tuesday 17 September 2024.\n \nInvestor Presentation\nJulian Baines, Executive Chair, and Stephen Young, Chief Financial Officer, will be hosting a live online presentation relating to the interim results via the Investor Meet Company (IMC) platform at 4.30pm (BST) on Wednesday 18 September 2024. The presentation is open to all existing and potential investors.\n \nInvestors can sign up to IMC for free and register for the presentation here: \nhttps://www.investormeetcompany.com/ekf-diagnostics-holdings-plc/register-investor\n \nInvestors who already follow EKF on the Investor Meet Company platform will automatically be invited.\n \nA recording of the presentation, a PDF of the slides used, and responses to the Q&A session will be available on the Investor Meet Company platform afterwards.\n \n \n\n\n\n\nEKF Diagnostics Holdings plc\n\n\nwww.ekfdiagnostics.com\n\n\n\n\nJulian Baines, Executive Chair / Stephen Young, CFO\n\n\nvia Walbrook PR\n\n\n\n\n\n\n\n\n\n\n\n\nSinger Capital Markets (Nominated Adviser & Broker)\n\n\nTel: +44 (0)20 7496 3000\n\n\n\n\nPhil Davies / Oliver Platts\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWalbrook PR Limited\n\n\nTel: +44 (0)20 7933 8780 or [email protected]\n\n\n\n\nPaul McManus / Charlotte Edgar\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \nAbout EKF Diagnostics Holdings plc (www.ekfdiagnostics.com)\nEKF is an AIM-listed global diagnostics business focussed on:\n \n\n\n\n\n●\n\n\nPoint-of-Care analysers in the key areas of Hematology and Diabetes \n\n\n\n\n●\n\n\nLife Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.\n\n\n\n\n \nEKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.\n \n\n","length":7196,"tagName":"div"}]